MEDS
DataMeds AI, Inc.Price
Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.
- X Jul 31 Short interest jumps 46.4% to 102.0K
- X Aug 14 Short interest jumps 61.6% to 164.8K
- R Aug 18 DataMeds AI (MEDS) reported Q2 2026 revenue of $1.78 million, down 7…
- X Sep 15 Short interest jumps 147.5% to 430.6K
- R Sep 17 DataMeds AI, Inc. settled litigation with former MIPA counterparties…
- E Sep 18 Trading halt: Halt Resumed: MEDS — trading resumed after LUDP (Volatilit…
- E Sep 18 Trading halt: Trading Halt: MEDS — LUDP (Volatility Trading Pause)
- R Oct 16 DataMeds AI entered into an IP license agreement with REBOOT Health…
Signal stack
Where each data set points today.
- TrendDOWNTREND
7% below its 50-day average.
- SocialQUIET
No Reddit mentions this week. Last mention Sep 28.
Who's buying
13F| Top holder | Shares | Value |
|---|---|---|
| JANE STREET GROUP, LLC | 20,532 | $63.6K |
| GEODE CAPITAL MANAGEMENT, LLC | 12,467 | $38.6K |
| VANGUARD CAPITAL MANAGEMENT LLC | 11,085 | $34.4K |
| VANGUARD FIDUCIARY TRUST CO | 6,191 | $19.2K |
| BARCLAYS PLC | 723 | $2.2K |
| DANSKE BANK A/S | 1 | $3.00 |
Quarterly 13F filings are due 45 days after each quarter ends.
Earnings setup
Estimates| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | — | — | — | $0.00 |
| Next Q | — | — | — | $0.00 |
| Current FY | — | — | — | $0.00 |
| Next FY | — | — | — | $0.00 |
Short side
FINRA· Oct 15, 2026| Sep 18, 2026 | Volatility Pause | Resumed |
| Sep 18, 2026 | Volatility Pause | Resumed |
| Sep 18, 2026 | Volatility Pause | Resumed |
| Sep 17, 2026 | Volatility Pause | Resumed |
| Sep 17, 2026 | Volatility Pause | Resumed |
SecBot reports
7 filings · 1 bullish · 2 bearish · 2 mixed · 2 neutral- BEARISH 8-KOct 26, 2026
DataMEDS AI entered a non-binding second amended and restated letter of intent to acquire QLPM intellectual property from EOS and Scilex, expand its PharmacyChain license with Datavault AI, acquire a controlling interest in Tollo Health/HLH, and license REBOOT Health AI's IP. The transaction would…
🔒 Fresh report (last 24h), subscribers only
- NEUTRAL 8-KOct 20, 2026
DataMeds AI, Inc. announced it has regained compliance with Nasdaq Listing Rule 5550(b)(1) after…
The delisting risk is resolved for now, but the caveat about the next periodic report means the next 10-Q or 10-K filing is the key catalyst. Monitor that filing for equity levels and any…
- MIXED 8-KOct 16, 2026
DataMeds AI entered into an IP license agreement with REBOOT Health AI, issuing 666,667 shares…
The delisting risk is materially reduced but not eliminated — monitor for Nasdaq's formal confirmation letter and the next periodic report for ongoing compliance. The IP license provides a strategic…
- MIXED 8-KOct 13, 2026
DataMeds AI filed an 8-K confirming stockholders' equity exceeds $2.5M, driven by two…
The ~$19M liability extinguishment significantly strengthens the balance sheet, but the 666,667-share license issuance creates dilution. Monitor the next 10-Q for the full impact on equity and any…
All MEDS filing & press-release reports (7)
- 8-K reportOct 26, 2026
- 8-K reportOct 20, 2026
- 8-K reportOct 16, 2026
- 8-K reportOct 13, 2026
- 8-K reportSep 17, 2026
- 8-K reportSep 16, 2026
- 8-K reportAug 18, 2026